Skip to main content
Livermore
Livermore
ZHEN

Visionary Wealth Advisors

SEC CIK
0001802984
Latest filing
Aug 13, 2026

BCRX holding history

Biocryst Pharmaceuticals Inc in every 13F filed by Visionary Wealth Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BCRX overviewAll 13F holders of BCRXFull Q2 2026 holdings

Shares (Q2 2026)
16,890
Value
$168.9K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BCRX by Visionary Wealth Advisors, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202616,890$168.9K<0.1%−3,000−15.1%ReducedHolders
Q1 202619,890$189.4K<0.1%−200−1.0%ReducedHolders
Q4 202520,090$156.7K<0.1%00.0%UnchangedHolders
Q3 202520,090$152.5K<0.1%−3,000−13.0%ReducedHolders
Q2 202523,090$206.9K<0.1%−3,500−13.2%ReducedHolders
Q1 202526,590$199.4K<0.1%00.0%UnchangedHolders
Q4 202426,590$200.0K<0.1%−1,200−4.3%ReducedHolders
Q3 202427,790$211.2K<0.1%−450−1.6%ReducedHolders
Q2 202428,240$174.5K<0.1%−300−1.1%ReducedHolders
Q1 202428,540$145.0K<0.1%00.0%UnchangedHolders
Q4 202328,540$171.0K<0.1%−5,000−14.9%ReducedHolders
Q3 202333,540$237.5K<0.1%−5,000−13.0%ReducedHolders
Q2 202338,540$271.3K<0.1%−1,400−3.5%ReducedHolders
Q1 202339,940$333.1K<0.1%+140+0.4%AddedHolders
Q4 202239,800$457.0K<0.1%+750+1.9%AddedHolders
Q3 202239,050$492.0K0.1%−5,400−12.1%ReducedHolders
Q2 202244,450$470.0K<0.1%+4,950+12.5%AddedHolders
Q1 202239,500$642.0K0.1%−5,625−12.5%ReducedHolders
Q4 202145,125$625.0K0.1%+3,650+8.8%AddedHolders
Q3 202141,475$596.0K0.1%+15,275+58.3%AddedHolders
Q2 202126,200$414.0K<0.1%+8,000+44.0%AddedHolders
Q1 202118,200$185.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.